Peptide Based Tuberculosis Treatment: A Million Dollar Question

Khusro, Ameer and Aarti, Chirom (2020) Peptide Based Tuberculosis Treatment: A Million Dollar Question. In: Emerging Research in Medical Sciences Vol. 3. B P International, pp. 79-84. ISBN http://bp.bookpi.org/index.php/bpi/catalog/book/118

Full text not available from this repository.

Abstract

Tuberculosis (TB) is a deadly tropical disease that is mainly caused by Mycobacterium tuberculosis.
The pathogen is known to invade and replicate inside the host’s macrophage. Due to the emerging
dilemma of multi-drug resistant TB and extensively-drug resistant TB, the exigency for finding new TB
drugs is an obligation now. Among the propitious anti-tubercular agents studied in the past few
decades, peptides from diversified sources have been substantiated to be persuasive with multiple
advantages such as low immunogenicity, selective affinity to bacterial negatively charged cell
envelopes and most importantly divergent mechanisms of action. This chapter highlights the role of
prime peptides exploited from several other unplumbed sources as anti-tubercular agents.

Item Type: Book Section
Subjects: Research Scholar Guardian > Medical Science
Depositing User: Unnamed user with email support@scholarguardian.com
Date Deposited: 22 Nov 2023 05:10
Last Modified: 22 Nov 2023 05:10
URI: http://science.sdpublishers.org/id/eprint/2215

Actions (login required)

View Item
View Item